E-MTAB-5632 - ChIP-seq of PDAC tissues grown as patient-derived tumor xenografts

Submitted on 28 August 2016, released on 29 May 2018, last updated on 12 June 2018
Homo sapiens
Samples (144)
Protocols (4)
Pancreatic adenocarcinoma (PDAC) is one of the most lethal human malignancies and a major health problem. Patient-derived tumor xenografts (PDTXs) have been increasingly used as a prime approach for preclinical studies despite being insufficiently characterized as a model of the human disease and its diversity. Extensive multiomics characterization of these PDTXs have demonstrated their utility as a suitable model for preclinical studies, representing the diversity of the primary cancers. We performed a multi-factorial integrative analysis of genome-wide ChIP-seq on multiple histone modifications, as well as RNA-seq on subcutaneous PDTXs from 24 PDAC samples obtained either surgically or using diagnostic biopsies (endoscopic ultrasound guided fine needle aspirate). In the dataset, ChIP-seq for five distinct histone marks (H3K4me1, H3K27ac, H3K4me3, H3K27me3, and H3K9me3) and RNA-seq was carried out to generate new knowledge on the epigenetic landscapes underlying the heterogeneity of PDAC tissues grown in this manner.
Experiment types
ChIP-seq, binding site identification design, disease state design
Exp. designProtocolsVariablesProcessedSeq. reads
Investigation descriptionE-MTAB-5632.idf.txt
Sample and data relationshipE-MTAB-5632.sdrf.txt